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ABSTRACT  Peptides  that stimulate astroglial  proliferation are produced  in traumatized adult 
rat brain by 10 d after injury. These same peptides are released by ameboid microglia activated 
in vitro. Our findings suggest that astroglial scarring is regulated in part by the release of factors 
from ameboid microglia near the site of brain injury. 
More than  50 years ago, Rio Hortega noted that injury to 
mammalian brain caused migration of ameboid microglia to 
the wound site (1). As these microglia (I, 2) engulfed cellular 
debris, astroglia proliferated and formed a scar. Although such 
glial responses might help to determine the success or failure 
of axonal regeneration (3-5), the mechanisms that regulate 
glial activity after brain injury remain unknown. Recent work 
on gliogenesis in the goldfish visual system and the mamma- 
lian brain showed the presence of peptides, referred to as glia- 
promoting factors (GPFs), 1 that selectively stimulated astro- 
glial or oligodendroglial proliferation in vitro (6-9). Moreover, 
the specific activities of the GPFs increased during periods of 
gliogenesis, suggesting that these factors regulated glial cellular 
responses in  vivo.  Our preliminary study showed that  the 
injured brain of the adult rat also contained elevated levels of 
GPFs. The search for cells which secrete GPFs during brain 
injury formed the basis for this report. 
MATERIALS  AND  METHODS 
Cell  Cultures:  Cerebral  cortices  isolated  from newborn albino  rats 
were gripped of the meninges, minced in a defined culture medium (10), and 
dissociated by trituration  in 0.25% trypsin in phosphate-buffered saline (PBS), 
pH 7.4. 100,000 cells were grown on poly-L-lysine-coated 22-mm  2 glass cover- 
slips in 35-ram plastic dishes at 37"C (8) with a humidified 95% air/5%  CO2 
atmosphere in defined medium containing  10% fetal bovine serum. After 48 
h, the cells were washed three times with defined medium.  10-100-pl aliquots 
of GPFs in PBS were added  to  1.5  ml defined culture  medium for 48-72-h 
incubations.  The final protein  concentrations  ranged from 0.05 to 5.00 tzg/ml 
culture. Buffer control cultures received matching aliquots of PBS alone. Under 
these conditions, there was a 150-250% increase in total cell number found in 
control cultures 7 d after cell plating. Enriched preparations  of oligodendroglia 
or astroglia  were prepared  with  modifications  of the  method described  by 
McCarthy and de Vellis (l l). 
Indirect  immunofluorescence  techniques  were  used  to  identify  astroglia 
containing  glial fibrillary acidic protein  (GFAP) or oligodendroglia with galac- 
t Abbreviations  used  in  this  paper:  GFAP,  glial  fibrillary  acidic 
protein; GPFs, glia-promoting factors; GS, goat serum. 
tocerebroside  (8). Cells adhering  to coverslips were washed with Dulbecco's 
minimal essential medium containing  20% heat-inactivated  goat serum (GS) 
and fixed for 30 min at -20"C with 90%  acetone/10%  acetic acid (vol/vol). 
The coverlips were dipped sequentially in  100% acetone, 70% ethanol,  PBS, 
and Dulbecco's  minimal essential medium with  1% GS. Rabbit  anti-human 
GFAP-antibody  (whole serum; Accurate Chemical  & Scientific Corp.,  West- 
bury, NY) was diluted  1:200 with Dulbecco's minimal essential medium with 
1% GS and was applied directly to the covershps. Coverslips were incubated 
for 45 min at 37"C in 95% air/5%  CO2 with high humidity  and were washed 
with Dulbecco's minimal essential medium.  A goat anti-rabbit  IgG conjugate 
of rhodamine isothiocyanate  (Accurate  Chemicals  &  Scientific  Corp.)  was 
diluted to 1:100 with Dulbecco's minimal essential medium-1% GS was next 
applied for 45 min at 37"C. Coverslips were washed five times with Dulbacco's 
minimal  essential medium-l% GS and distilled H20 and were mounted in 
glycerol containing  1 mg/ml ofp-phenylenediamine  and 10% PBS. Fluorescent- 
labeled cells were viewed at x  200 with a Nikon Diaphot  microscope using 
epifluorescence.  Identification  of galactocerebroside-positive  oligodendroglia 
was carded  out in a similar fashion with cell fixation after antibody binding. 
Rabbit  anti-galactocerebroside serum,  produced  in our laboratory,  was used 
with a dilution of 1:100. 
Ameboid  microgha (12) were isolated from mixed glial cultures grown in 
75-cm  2 plastic culture flasks containing  10 ml defined medium with 10% fetal 
bovine serum at a density of 85,000 cells/ml. After 7 d, confluent cultures were 
vigorously agitated on a rotary shaker for 15 h (37°C; 180 rpm). The resulting 
suspension, containing process-bearing cells and mieroglia, was transferred to 
a new 75-cm  2 culture flask. After a 3-h adhering interval, process-bearing cells 
were suspended by gently shaking flasks at room temperature.  This cell suspen- 
sion was discarded. Each flask was then treated with 0.2% trypsin in defined 
medium and vigorously shaken by hand to release adhering microglia. Once 
the majority of the microglia had been resuspended, fetal bovine serum was 
added to the defined medium (15% final volume) and the cell suspension added 
to new plastic flasks. After a second 3-h interval to allow adhesion, the medium 
was removed,  and adhering  microglia were resuspended  using trypsin.  Final 
preparations  showed a nearly homogeneous population  with 95% nonspecifie 
esterase-positive microglia (Giulian,  D., and T. J.  Baker, unpublished  data). 
There was a 10% recovery of  all esterase-positive microglia found in the starting 
cultures. These ameboid  microglia showed the MAC-I  and MAC-3 antigens, 
an ability to engulf 5-urn latex beads, and the presence of the acetylated low 
density lipoprotein receptor (Giulian,  D., and T. J.  Baker, unpublished  data; 
see  also  references  2  and  12). Fixed  Staphylococcus  aureus in  suspension 
(Pansorbin,  Calbiochem-Behring Corp.,  La Jolla, CA) was used to stimulate 
microglial secretions (20 ul added per 1.5 ml culture medium). Unlike periph- 
eral blood monocytes,  microglia were peroxidase negative and in contrast  to 
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unpublished data; see also references 2 and 12). Microglia could be selectively 
destroyed using L-leucine  methyl ester, a lysosomotrophic  agent effective  against 
phagocytic cells (14). 
Isolation of CPFs:  Four GPFs have been isolated from goldfish brain 
(6-9). Two of these peptides, GPFt  (estimated molecular mass 15 kD) and 
GPFs (6 kD), acted upon oligodendroglia  while GPF2 (9 kD) and GPF4 (3 kD) 
served as mitogens for astroglia (8). In this study, we examined GPFs isolated 
from the brain of rat. Anesthetized  adult female rats (Holtzman Co., Madison, 
WI) received from 10 to 15 puncture wounds in the cerebral cortex to a depth 
of 3 mm using a 26-gauge needle. The damaged cortex was isolated 10 d after 
surgery with the contralateral hemisphere providing intact tissue control. Brain 
samples were dispersed by sonication in ice-chilled PBS and centrifuged at 
15,000 g for 30 min. The supernatants were filtered through 0.45-~m filters 
and applied to a standardized gel filtration column (Bio-Rad Laboratories, 
Richmond, CA; P-10, 100 x 0.9 cm). Defined culture media conditioned for 
24 h by enriched populations of ameboid microglia were concentrated using 
ultrafiltration (YM-2, Amicon Corp., Danvers, MA) and fractionated by gel 
filtration as described for brain  material. Each fraction was  tested for its 
mitogenic effect upon  of oligodendroglia or astroglia. We found that  the 
apparent molecular masses and specificity  of biologic activities were the same 
for GPFs isolated from fish and rat brain (8, 9). Furthermore, fish and rat GPFs 
co-porified using ion exchange chromatography and reverse-phase high per- 
formance liquid chromatography, which suggests that these factors were struc- 
turally similar (Giulan, D., and T. J. Baker, unpublished data; see also references 
8 and 9). GPFs in brain supernatants from injured and intact adult rats or 
conditioned media from activated and control microglia were separated by 
consecutive  column elutions. Pooled fractions containing biologic  activity were 
matched for the experimental and control groups and used to determine dose 
responses. 
Mean cell numbers were calculated for each culture by scoring the number 
of fluorescently labeled astroglia or oligodendroglia found in  l0 randomly 
selected microscopic fields (0.314 mm2). Data were expressed as fold increase 
in cell number when compared to PBS-treated control cultures (8). Protein 
concentrations were estimated using the fluoreseamine method with bovine 
serum albumin  standards (15). Gel  filtration provided a  250- to  500-fold 
purification for brain GPFs and a 100- to 300-fold purification for microglial 
GPFs. 
RESULTS  AND  DISCUSSION 
The events which lead to astroglial proliferation in the injured 
mammalian  brain are not known  (1,  2).  Our laboratory has 
identified four brain-derived peptides, glia-promoting factors 
(GPFs),  that  stimulate the proliferation of specific glial pop- 
ulations  in  culture  (6-9).  Increasing  levels of GPFs  during 
periods of gliogenesis in the regenerating goldfish visual sys- 
tem  and  in  the  developing  rat  brain  suggested  that  these 
peptides regulated glial growth in vivo (6-9).  We questioned 
whether  GPFs  also  played  a  role  in  mediating  cellular  re- 
sponses in traumatized adult mammalian brain. 
The damaged brain extract was fractionated using gel filtra- 
tion and assayed for the presence of GPFs by incubation with 
mixed glial cultures grown in defined medium (8). The super- 
natant  contained  factors  that  stimulated  the  appearance  of 
astroglia in culture with peaks of biologic activity correspond- 
ing to GPF2 (apparent molecular mass of 9 kD) and GPF4 (3 
kD) (8). 2 Adult rat cortex  10 d  after stab wound  injury did 
not contain detectable levels of the oligodendroglia-stimulat- 
ing  factors,  GPF~  or  GPFs  (Figs.  1  and  2).  Dose-response 
curves  showed  a  three-  to  fourfold  increase  in  the  specific 
activities of GPF2 and GPF4 recovered from damaged brain 
when compared to those obtained from intact control tissue 
(Fig. 2). 
To  determine  the  cellular  sources  of astroglia-promoting 
peptides, we assayed for GPFs in medium conditioned by rat 
2 The injured brain  also contained a  third  growth  factor (18  kD), 
which has been identified as interleukin-1 (data not shown; see also 
reference 16). 
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FIGURE  1  Recovery of GPFs from injured mammalian brain. Solu- 
ble protein was applied to a P-10 column (100 x 0.9 cm) and eluted 
with sterile PBS, pH  7.4.  100-/A aliquots of each  fraction  were 
assayed for the ability to increase the number of astroglia (upper 
panel)  or oligodendroglia (lower panel)  grown on  poly-t-lysine- 
coated coverslips in  35-mm dishes  containing 1.5  ml of defined 
medium. Mean numbers of cells per mm  2 were calculated for each 
culture,  using  indirect immunofluorescence techniques with ga- 
lactocerebroside as a  marker for  oligodendroglia and  GFAP  for 
astroglia.  Data  were expressed  as the degree of increase  in  cell 
number when compared with a control culture incubated with 100 
#1 of PBS. Each data point represented a  mean value calculated 
from three cultures. 50 mg of soluble protein from a supernatant of 
injured rat cerebral cortices (injured) showed two peaks of astroglia- 
stimulating activity. These  peaks contain the peptides, GPF2 and 
GPF4, which are also recovered from regenerating goldfish visual 
system and the developing rat brain (6-9). Supernatant  from con- 
tralateral intact hemispheres (control) processed in identical fashion 
did not show gila-stimulating activity. Molecular mass markers:  (a) 
17 kD; (b) 14.5 kD; (c) 9.2 kD; (d) 6.4 kD; (e) 2.5 kD. 
brain cultures. Initial study showed that neuron-free cultures 
containing  mixed  populations  of cells  produced  astroglia- 
stimulating  GPFs.  We  next  examined specific gliai popula- 
tions  found  in  these  cultures  (oligodendroglia,  astroglia,  or 
microglia)  for  the  production  of GPF2  and  GPF4  (Fig.  3). 
Medium conditioned  for 24  h  by astroglia,  oligodendroglia, 
or microglia did  not  stimulate  the proliferation  of astroglia 
(Fig. 3).  As noted earlier, glia engulf cellular debris found in 
injured  brain  tissue  (1,  2).  Since phagocytosis  is  known  to 
activate  monocyte  secretion  of growth  factors  (17),  we  at- 
tempted  to  activate the  release  of GPFs  by  incubating  glia 
with  a  potent  phagocytic  signal,  fixed  S.  aureus  (14).  We 
found that only "stimulated" microglia (Fig.  3) released sig- 
nificant amounts of the astroglia-promoting factors. 
The  microglial secretion products  were further  character- 
ized by gel filtration as described for injured brain superna- 
tants.  Defined  medium  conditioned  by  activated  microglia 
for 24 h  contained astroglia-stimulating activity which corre- 
sponded to GPF2 (9 kD) and GPF4 (3 kD, Fig. 4).  Microglia 
did not release detectable amounts of oligodendroglia-stimu- -  6  GPFI 
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FIGURE 2  Dose-response  for GPFs found  in supernatants  of  in- 
jured or intact rat cerebral cortex. Fractions from tissue supernatants 
recovered  by gel  filtration were screened  for biologic activity as 
described in legend  to Fig. 1. Pooled  fractions containing specific 
GPFs were compared to pooled matching fractions obtained from 
intact tissue  controls. Data  were expressed  as degree  increase  in 
the number of astroglia or oligodendroglia. Each value represented 
a  mean  score  calculated from  at  least five cultures. The protein 
concentration in pooled fractions was estimated  by the fluoresca- 
mine method using bovine serum albumin standards.  Increases in 
the specific activity of GPF2 and GPF4 were observed after injury to 
the rat brain. 
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FtGURE 3  Proliferation  of  astroglia  in  the  presence  of  medium 
conditioned by enriched glial cell cultures. Approximately 20,000 
cells of isolated  microglia (95% nonspecific esterase-positive cells) 
astroglia  (98% GFAI  ~*) cells) or oligodendroglia (92% galactocere- 
broside-positive cells)  were grown in 35-ram  culture dishes  con- 
taining 1.5 ml defined medium in the presence or absence of fixed 
5.  aureus  (20-/~1 suspension). After 24 h, 150 #1 of these conditioned 
media  were assayed for astroglia-stimulating activity as described 
in Materials and Methods. Only microglia which were activated by 
S.  aureus  released factors that stimulated proliferation of astroglia. 
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FIGURE 4  Medium conditioned by activated microglia contained 
GPF2 and GPF4. 100,000  ameboid  microglia were grown in a 75- 
mm  2 culture flask containing 7 ml of defined medium. Microglia 
were activated by addition of a suspension of 150 pl fixed 5.  aureus 
for 24 h. Conditioned medium was concentrated to 1 ml by ultra- 
filtration, applied to a standardized  gel filtration column, and as- 
sayed as described in legend to Fig. 1. Molecular mass markers: (a) 
17 kD; (b) 14.5 kD; (c) 9.2 kD; (d) 6.4 kD; (e) 2.5 kD. 
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FIGURE  5  Dose-re- 
sponse curves for GPFs 
isolated  from activated 
or  control  populations 
of  ameboid  microglia. 
GPFs  found  in  media 
of  microglia incubated 
with or  without S.  au- 
reus  were  isolated  by 
gel  filtration  as  de- 
scribed in legend to Fig. 
4.  Activated  microglia 
showed  a  marked  in- 
crease in the secretion 
of GPF2 and GPF4 when 
compared  with  me- 
dium  from  matching 
control preparations. 
GIULIAN  AND  BAKER  Microglia Stimulate Astroglia  2413 FIGURE  6  (A) A  phase-contrast  photo- 
micrograph  shows  the  enriched  popu- 
lation  of  nonspecific  esterase-positive 
microglia that were isolated by adhesion 
techniques. (B) A phase-contrast  photo- 
micrograph of enriched astroglial culture 
stained  for  nonspecific  esterase after 
treatment with 5  mM  L-leucine methyl 
ester. This treatment eliminated nonspe- 
cific  esterase-positive  microglia.  (C,  E, 
and  G)  Phase-contrast  micrographs  of 
enriched glia preparations  that were in- 
cubated for 2 h with 20 p,I of suspended 
fixed  S.  aureus,  washed  with fresh  de- 
fined medium, and after 48 h in culture 
were  stained  for  GFAP  (D,  F,  and  H). 
Cultures of enriched microglia (C and D) 
activated by phagocytosis of fixed S. au- 
reus.  Faint,  nonspecific  fluorescence 
staining  (D)  for  GFAP  was  associated 
with the engulfed bacteria.  Cultures of 
astroglia incubated with fixed bacteria (E 
and F) grow at a rate  similar to that of 
untreated control cultures (see Table I). 
Astroglia proliferated  rapidly, however, 
when grown together with activated mi- 
croglia (G and H). Arrow (G) indicates a 
microglial  cell  atop  astrocytes.  Bar, 25 
/~m. 
lating  factors.  Dose-response  curves  demonstrated  that  S. 
aureus  increased the secretion of GPF2 and GPF4 by three- to 
fivefold when compared to unstimulated microglial cultures 
(Fig. 5). Further analysis of  brain and microglial GPFs showed 
the  astrogiia-stimulating  factors  co-purified  by  anion  ex- 
change chromatography (DEAE-5PW, Beckman Instruments, 
Inc., Palo Alto, CA; 0.5  M  NaC1 gradient) and by reverse- 
phase high performance liquid chromatography (C3 column, 
BioRad Laboratories; 20-70% acetonitrile gradient with  10 
mM trifluoroacetic acid; Giulian, D., and R. Allen,  unpub- 
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lished data). Based upon purification profiles,  the specificity 
of biologic activities, and  the stimulated  release  of growth 
factors, we concluded that activated microglia were a likely 
source of astroglia-stimulating peptides recovered from in- 
jured brain. 
To test for a direct stimulatory action of microglia upon 
astrogiia,  we next examined glia-glia interactions by co-cul- 
ture of enriched cell populations. We monitored the prolifer- 
ation of the GFA1  ~+) astroglia that  were grown  in  defined 
medium for 48 h in the presence or absence of microglia (Fig. TABLE  I.  Effects of Co-culture upon Astroglial Proliferation 
Cell culture conditions 
Fold in- 
Number  crease 
GFAP  I+) astro-  over 
gila per mm 2  control 
Astroglia only (control)  11.5 _+ 3.0  1.0 
Microglia only  <0.1  -- 
Astroglia +  S. aureus  8.8 _  1.3  0.8 
Astroglia +  microglia  21.6 _  1.5  1.9 
Astroglia +  microglia +  S. aureus  65.9 +  8.2  5.7 
Cultures of enriched astroglia (11) or microglia were grown on poly-t-lysine- 
coated  coverslips  in  35-ram  plastic  dishes  containing  1.5  ml  of  defined 
medium.  Cells were  incubated with  or without  20 #1 of suspended fixed 
Staphylococcus  aureus (5.  aureus,  Pansorbin,  obtained  from  Calbiochem- 
Behring Corp.) for 2 h in 10% fetal bovine serum. Cultures were then washed 
with  fresh defined medium  and 48 h later were stained by indirect immu- 
nofluorescence for glial fibrillary acidic  protein  (GFAP)  found  in  astroglia. 
Data were expressed as mean number cells per mm  2 -+ SEM. Cell numbers 
were computed from 10 randomly selected fields from each of five cultures 
per experimental group. Only those cultures containing microglia activated 
by S. aureus showed a significant increase in number of astroglia. 
6). There was a five- to sixfold increase in astroglial number 
when these cells were grown with  microglia that had been 
stimulated with S. aureus (Table I). Since S.  aureus did not 
alter astroglia proliferation in the absence of microglia, we 
concluded that microglia acted as effector cells to promote 
the growth of astroglia in culture. 
The implications of our in vitro data need to be considered 
cautiously. First, it is likely that GPFs represent only one of 
many regulatory mechanisms that control glial cell growth in 
vivo. Secondly, the ability of secreted products to influence 
cell growth depends not only upon the quantity and potency 
of the growth factor released but also the number of secretory 
cells and the availability of targets. Although different brain 
cell populations may produce GPFs in vivo, we believe ame- 
boid microglia, which infiltrate wound sites soon after central 
nervous system injury,  are  a  principal  source  of astroglia- 
stimulating peptides. 
Two peptides which served as mitogens for astroglia were 
recovered from injured brain tissue and were released in vitro 
by stimulated ameboid microglia. We suggest that activated 
microglia release factors that regulate astroglial growth and 
proliferation  at  sites  of brain  injury.  Therapies to  control 
microglial  responses  might  therefore  reduce  astroglial  scar 
formation associated with brain injury. 
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